ImmuGT-ConRes: a consistency learning residual network for predicting pan-cancer immunotherapy response from gene expression data

Engineering notes

We demonstrated that ImmuGT-ConRes exhibited superior predictive performance and provided interpretability by ranking gene weights based on the attention mechanism, providing an effective approach for immunotherapy target mining.

Chinese explanation / 中文解读

中文解读待补充：本站会优先为端到端自动驾驶、BEV感知、3D目标检测、轨迹预测、路径规划、LiDAR感知等高价值论文补充中文说明。

Original abstract

Immunotherapy is leading the transformation in cancer treatment, but its response rate remains low, and there is a scarcity of immune targets that can produce lasting effects. Multi-omics data is widely used in immunotherapy. However, traditional analysis methods often struggle to uncover hidden correlations within the data, limiting the exploration of potential immunotherapy targets. Here, we pooled immunotherapy data from over 40 cohorts and developed ImmuGT-ConRes (Genomic Image Transformation with Consistency Learning and Residual Networks). ImmuGT-ConRes uses a contrastive learning approach, incorporating a dual-branch data augmentation strategy and a multi-scale stride convolution structure. By integrating residual networks and attention mechanisms, ImmuGT-ConRes adapts to multi-scale gene feature capture, reduces information loss between shallow details and deep semantics, and enhances the model's robustness to input perturbations. We demonstrated that ImmuGT-ConRes exhibited superior predictive performance and provided interpretability by ranking gene weights based on the attention mechanism, providing an effective approach for immunotherapy target mining. These results suggest that ImmuGT-ConRes offers a promising framework for immunotherapy target discovery and merits further investigation.

Links and sources

• PDF from original source

Comments